(Q43720284)

26 November 2017

Statistical issues in bioequivalence [correction of bioequivalance]. (English)

1 reference

26 November 2017

1 reference

S Senn

1

1 reference

PubMed ID

11523083

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

Statistics in Medicine

1 reference

26 November 2017

20

1 reference

26 November 2017

17-18

1 reference

26 November 2017

2785-2799

1 reference

Use of confidence intervals in analysis of comparative bioavailability trials.

26 November 2017

1 reference

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

21 January 2018

1 reference

Consideration of individual bioequivalence

21 January 2018

1 reference

Towards a practical strategy for assessing individual bioequivalence. Food and Drug Administration Individual Bioequivalence Working Group

21 January 2018

1 reference

Joint equivalence of means and variances of two populations.

21 January 2018

1 reference

Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator

21 January 2018

1 reference

Symmetrical confidence intervals for bioequivalence trials

21 January 2018

1 reference

In the blood: proposed new requirements for registering generic drugs

21 January 2018

1 reference

Individual bioequivalence. New concepts in the statistical assessment of bioequivalence metrics. FDA Individual Bioequivalence Working Group

21 January 2018

1 reference

The pharmacologic and clinical properties of Oxis (formoterol) Turbuhaler

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SIM.743

1 reference

26 November 2017

1 reference

PubMed ID

11523083